Diagnosis and treatment of metastatic and castration resistant prostate cancer became more and more and complex due to the increasing knowledge and understanding of the underlying molecular events and the subsequently deducted innovative medical treatment
Modern imaging studies in CRPCA have become more and more complex and selective and currently include positron emission tomography, whole body magnetic resonance imaging, immunoscintigraphy besides the traditional studies such as bone scans and computed tomography.
About the Editors
Kurt Miller MD, PhD
Professor Miller has been Chairman and Professor of Urology for the Department of Urology at the Benjamin Franklin Medical Center, Berlin, Germany, since 1993. In 2007 he became Chairman of the ...
Read more »
Axel Merseburger MD, PhD
Prof Axel S. Merseburger is currently Vice Chairman of the Department of Urologic Oncology, as well as Director of the Urologic Oncology Programme at Hannover Medical School, Germany. ...
Read more »
30 October - 2 November
National Meeting of the Portuguese Association of Urology
Contact: Portuguese Association of Urology
Tel.: +351 21 324 3590
Fax: +351 21 324 3599
31 October - 3 November
SUNA 45th Annual Conference
Lake Buena Vista, FL, USA
Contact: Society of Urologic Nurses and Associates
Tel.: +1 856 256 2335
Fax: +1 856 589 7463
ESU organised course on Non–muscle-invasive Urothelial Cancer to be held during the National Congress of the Portuguese Association of Urology
Contact: European School of Urology (ESU)
Tel.: +31 26 389 0680
Fax: +31 26 389 0674